The emergence of the multiresistance gene cfr in staphylococci is of global concern. In addition to conferring resistance to phenicols, lincosamides, pleuromutilins, streptogramin A antibiotics and selected 16-membered macrolides, the cfr gene also confers resistance to the oxazolidinone linezolid. Linezolid is a last-resort antimicrobial agent for the treatment of serious infections in humans caused by resistant Gram-positive bacteria. The cfr gene is often located on plasmids and several cfr-carrying plasmids have been described, which differ in their structure, their size and the presence of additional resistance genes. These plasmids are important vehicles that promote the spread of the cfr gene not only among bacteria of the same species, but also among those of different species and genera. Moreover, the cfr gene has been identified in close proximity to different insertion sequences, which most probably also play an important role in its dissemination. This review summarizes current knowledge on the genetic environment of the multiresistance gene cfr with particular reference to mobile genetic elements and co-located resistance genes that may support its emergence.
Introduction
The cfr gene encodes an RNA methyltransferase that modifies the adenine residue at position 2503 of the 23S rRNA gene and thereby confers combined resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A antibiotics (otherwise known as the PhLOPS A phenotype), 1, 2 and decreased susceptibility to the 16-membered macrolides spiramycin and josamycin. 3 These classes of protein biosynthesis inhibitors share overlapping binding sites at the peptidyltransferase centre of the ribosome. It is believed that the additional methylation of A2503 interferes with the correct positioning and binding of the aforementioned classes of antimicrobial agents. Cfr-mediated resistance to linezolid, the first and so far only approved oxazolidinone for human clinical use, has gained particular attention since oxazolidinone resistance was believed to be based almost exclusively on mutations in 23S rRNA or the genes for the ribosomal proteins L3 and L4. 4 The cfr gene is currently the only gene that confers transferable resistance to oxazolidinones in clinical isolates, although cfr-like genes have recently been identified in environmental members of the order Bacillales and shown also to confer the PhLOPS A phenotype. 5 Linezolid is considered to be a last-resort antimicrobial agent for the treatment of infections caused by vancomycinresistant enterococci, methicillin-resistant Staphylococcus aureus (MRSA) and penicillin-resistant pneumococci. 6 Therefore, the transferable linezolid resistance conferred by the multiresistance gene cfr poses a significant and interdisciplinary public health challenge. 7 Since its initial identification in a bovine Staphylococcus sciuri isolate in 1997, 8 the cfr gene has been documented globally in linezolid-resistant clinical staphylococcal isolates of human and animal origin. 4, 7, 9 Although most reports have identified this gene in staphylococci [including methicillin-susceptible S. aureus (MSSA) and MRSA, various coagulase-negative staphylococci (CoNS) and the coagulase-variable S. hyicus], recent studies have described it in four other genera of Grampositive bacteria, namely Bacillus, 10 -12 Enterococcus, 13 -16 Macrococcus and Jeotgalicoccus, 17 as well as in members of two genera of Gram-negative bacteria, Proteus and Escherichia. 18, 19 This observation indicates that cfr-mediated resistance is more widespread than initially thought. With the exception of the Enterococcus isolates, the cfr-positive isolates of the other five non-Staphylococcus genera were obtained exclusively from livestock and related farm environments. Since the epidemiology and resistance mechanism of cfr in staphylococci have been extensively reviewed elsewhere, 4, 7, 9 this review will provide an update on the genetic environment of the multiresistance gene cfr in the different host bacteria. This information will provide an insight into the processes that are likely to be involved in the dissemination of cfr across strain, species and genus boundaries.
Genetic environment of cfr in Staphylococcus spp.
Most of the cfr-positive animal isolates originated from swine, although isolates of bovine, equine and-most recently-poultry origin have also been reported. 20 -25 So far, cfr has been discovered in nine staphylococcal species of porcine origin, including S. aureus (plasmid pSCFS3), 20, 21 S. lentus (pSCFS3), 20 S. warneri (pSCFS6), 22 S. simulans (pSCFS6), 22 S. hyicus (chromosomal location), 22 S. cohnii (pSS-01, pSS-03, pBS-01 and chromosomal location), 23 S. arlettae (pSS-03 and chromosomal location), 23 S. saprophyticus (pSS-01, pSS-02, pSS-03, pBS-01 and chromosomal location) 23 and S. sciuri (pSS-02, pSS-03, pBS-01 and chromosomal location). 20, 23 It has also been detected in four staphylococcal species of bovine origin, namely S. lentus (pSCFS3), S. simulans and S. sciuri (both pSCFS1). 8, 20 The genetic context of the cfr gene in all these plasmids has been well characterized. Occasionally, indistinguishable or very closely related plasmids, such as pSCFS1, pSS-02 and pSS-03, have been found in isolates of different staphylococcal species. This observation may point towards the role of plasmids in the interspecies transfer of the cfr gene.
For isolates of human clinical origin, the first documented strain to harbour a chromosomally located cfr gene was MRSA strain CM05, isolated from a patient in Medellin, Colombia, in 2005. 26 This gene has subsequently been detected among linezolid-resistant clinical staphylococci (mainly S. aureus and coagulase-negative S. epidermidis) of diverse geographical origin (USA, Belgium, Italy, Spain, Mexico and Ireland). 27 -35 Even though cfr has been reported in several human clinical staphylococcal isolates, its genetic context has only been characterized in MRSA plasmids p004-737X, pSCFS7 and pERGB, as well as on the chromosome of MRSA strain CM05 and plasmid p7LC of S. epidermidis strain 426-3147L. 31,34 -37 The partial sequence of the cfr-harbouring plasmid pMHZ from the S. capitis strain MHZ, which originated from an outbreak of linezolid-resistant CoNS in two hospitals in China, was recently obtained from the NCBI GenBank database (accession no. JX232067). The genetic environment of 14 plasmidic or chromosomal cfr genes from Staphylococcus spp. is presented in Figure 1(a) . Comparative sequence analysis of the available Staphylococcus cfr-carrying segments revealed three interesting characteristics.
First, although the cfr gene has been identified both in chromosomal DNA and on plasmids of various sizes, the immediate genetic environment of cfr is sufficiently similar to suggest a limited number of acquisition events that explain the diversity seen among the plasmidic or chromosomal structures. In this regard, insertion sequences and pre/mob genes found in close proximity to cfr demand particular attention. For instance, the insertion sequence IS21-558 co-localizes with cfr and has been reported to play an important role in the mobility of this gene.
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IS21-558 has been identified on plasmids pSCFS3, pSS-02 and pSCFS6 from veterinary staphylococcal isolates, 20 -23 as well as on plasmids p004-737X and pERGB and on the chromosome of MRSA strain CM05 from human clinical isolates. 31, 35, 36 In addition, a truncated IS21-558 was observed upstream of the cfr gene on conjugative plasmid pSCFS7 from a human clinical MRSA isolate. 34 IS21-558 and cfr were frequently integrated into transposon Tn558, which carries the phenicol exporter gene fexA. 22, 23 On plasmids pSCFS3, pSS-02, pSCFS6, p004-737X and pSCFS7, Tn558 was disrupted or in part truncated by the respective insertions ( Figure 1) . Although identified from different staphylococcal species of porcine and bovine origin on different continents, plasmids pSS-02 and pSCFS3 are of a similar size, share indistinguishable BglII fragment patterns and do not contain additional antimicrobial resistance genes. 23 Moreover, we recently identified a pSS-02-like plasmid among methicillin-resistant CoNS from human infections in China. 38 In addition to IS21-558, an IS256-like element (later designated ISEnfa4) originally identified in pSS-01 was another IS element recognized as being associated with the cfr gene in staphylococci. In pSS-01, the cfr gene was flanked in the upstream region by a Tn4001-like transposon with an IS256-like element at the right-hand terminus, and in the downstream region by another IS256-like element. A complete Tn558 transposon, including the fexA gene, was found further downstream of this IS element. 23 In the clinical S. capitis strain MHZ, the 5.2 kb segment of pMHZ comprised the cfr gene and its flanking IS256-like elements and closely resembled (99.9% identity) the corresponding region of plasmid pSS-01. On plasmids pSCFS1, pSS-03 and pMSA16, the cfr gene was flanked in the downstream region by a pre/mob gene for plasmid recombination and mobilization whose deduced amino acid sequences showed .95% identity to each other ( Figure 1 ). Similarly, a truncated copy of a pre/mob gene, whose deduced amino acid sequences showed .99% identity to the 271 amino acids at the C terminus of the Pre/mob protein from plasmid pSES22 39 (GenBank accession no. CAJ43794), was located upstream of the cfr gene on plasmids pSS-03, pMSA16 and pBS-01.
Second, cfr-carrying plasmids or chromosomal fragments often carry additional resistance genes. In addition to the coexistence of the Tn4001-associated aminoglycoside resistance gene aacA-aphD and cfr in pSS-01 and p7LC, the 50 kb conjugative plasmid pERGB contains three resistance genes, namely the kanamycin/neomycin resistance gene aadD, the tetracycline resistance gene tet(L) and the trimethoprim resistance gene dfrK, located downstream of cfr and flanked by two divergently orientated copies of insertion sequence element IS431. 35 These two copies of IS431, as well as the resistance genes, were highly similar to those previously described for the staphylococcal multiresistance plasmids pKKS825 and pKKS2187. 40, 41 In the 15.5 kb cfr insertion region that was found to disrupt the 23S rRNA allele 4 in the chromosomal DNA of S. aureus CM05, the IS21-558 element and the cfr gene were flanked by two 1.5 kb Tn917-derived repeated elements. These elements carry the rRNA methylase gene erm(B), which confers resistance to macrolide -lincosamide -streptogramin B (MLS B ) antibiotics. Interestingly, a recombination event involving the two erm(B)-carrying segments can occur in CM05, leading to the deletion of cfr and IS21-558. 36 An intact Tn917 element harbouring the erm(B) gene was also located downstream of the cfr gene in plasmid pBS-01. 23 Three other distinct MLS B resistance genes, erm(A), erm(C) and erm (33) , were detected on plasmids pMSA16, pSS-03 and pSCFS1, respectively. 23, 24, 42 As a novel MLS B resistance gene, erm(33) on pSCFS1 represented an in vivo derived 'in-frame' recombination product of the erm(C) and erm(A) genes. 43 Moreover, pSCFS1 carries two additional resistance genes: the spectinomycin adenyltransferase gene spc as part of transposon Tn554 located downstream of erm (33), and an ABC Review Review 1699 transporter gene lsa(B) conferring low-level clindamycin resistance and found immediately upstream of the cfr gene. 42 It should be emphasized that the coexistence of cfr with additional resistance genes could allow for the persistence and co-selection of the cfr gene under selective pressure imposed by the use of the corresponding non-PhLOPS A antimicrobial agents.
Third, with a similar size of 7.1 kb, the plasmids pSS-03 and pMSA16 are the smallest cfr-carrying plasmids known to date. 23, 24 The 6.3 kb cfr-carrying segment of pSS-03 from porcine CoNS closely resembles (99.6% identity; 6271/6298 bp) the corresponding region of plasmid pMSA16 from a bovine MRSA ST9 strain. Only the MLS B resistance genes differ between the two plasmids, with the erm(A) and erm(C) genes located downstream of the recombination/mobilization gene pre/mob in pMSA16 and pSS-03, respectively. Moreover, similar to the widespread occurrence of plasmids pSCFS3/pSS-02, plasmid pSS-03 has been found in four different porcine staphylococcal species and recently in one porcine Macrococcus caseolyticus strain, 17, 23 indicating that this small plasmid has a broad host range. In addition, a 4.6 kb cfr-carrying segment, including the cfr, pre/mob and partial erm(C) genes from pSS-03, also shows high nucleotide sequence identity (96.4%, 4519/ 4689 bp) to the corresponding region [cfr, pre/mob, and partial erm(33)] of plasmid pSCFS1 (Figure 1a ). These observations suggest that (i) the gene cfr can be part of structurally diverse plasmids, (ii) small cfr-carrying plasmids can be integrated in part into larger plasmids and (iii) small cfr-carrying plasmids may be able to replicate in other bacterial hosts. The latter observation corresponds closely to previous observations that tet(L)-or aadD-carrying plasmids found in staphylococci can also replicate in Bacillus hosts. 44 Genetic environment of cfr in other Gram-positive bacteria
The immediate genetic environment of the cfr gene in other Grampositive bacteria is much more diverse than that in Staphylococcus (Figure 1b) . To date, the cfr gene has been found to be plasmidborne in four non-staphylococcal Gram-positive bacterial genera, namely three Bacillus strains, five Enterococcus strains, two Macrococcus strains and one Jeotgalicoccus strain.
cfr in Bacillus, Macrococcus and Jeotgalicoccus spp.
A Bacillus isolate of porcine origin was the first identified nonstaphylococcal isolate harbouring the cfr gene. 10 To date, three cfr-carrying plasmids, pBS-01 (16 492 bp), pBS-02 (16 543 bp) and pBS-03 (7446 bp), have been identified in Bacillus isolates, all of which are of porcine origin and originate from the Shandong Province, China. 10 -12 Plasmid pBS-01 contains a complete copy of transposon Tn917, whereas plasmid pBS-02 contains an insertion that includes an IS256 element and the two genes res and met (Figure 1b) . Whether the IS256, which is located immediately downstream of the cfr gene in pBS-02, has played a role in the acquisition of cfr and its dissemination among Bacillus species remains to be answered. 11 Plasmid pBS-03 is the smallest identified cfr-carrying plasmid from Bacillus spp. and contains the novel streptomycin resistance gene aadY. 12 A 4516 bp segment in pBS-03 containing the truncated Dpre/mob, cfr and the intact pre/mob gene shares 99.7% nucleotide identity with the corresponding sequence of plasmid pSS-03, which has been identified in both Staphylococcus and Macrococcus isolates.
A novel 53 kb cfr-carrying plasmid pJP1 was identified in an M. caseolyticus isolate and in a J. pinnipedialis isolate, both from pigs. 17 Plasmid pJP1 is the only known non-staphylococcal plasmid that carries an IS21-558 element adjacent to the cfr gene. Moreover, the genes aadD, aacA-aphD, ble and erm(C), the first two coding for aminoglycoside resistance, and the latter two for bleomycin and MLS B resistance, respectively, were also identified on this plasmid. 17 The occurrence of cfr-harbouring plasmid pBS-01 in both Bacillus and Staphylococcus isolates, pJP1 in both Macrococcus and Jeotgalicoccus isolates and pSS-03 in both Staphylococcus and Macrococcus isolates suggests that these plasmids can spread between different Gram-positive genera.
cfr in Enterococcus spp.
The identification of cfr in the human MRSA strain CM05 suggested enterococci as a possible source of this multiresistance gene. 26 However, the presence of cfr in human clinical enterococcal isolates was not reported until 2010, 45, 46 and an in-depth characterization of these isolates for their cfr regions has yet to be published. Recently, a linezolid-resistant E. faecalis isolate belonging to the multilocus sequence type (MLST) ST16 was recovered from a patient in Thailand.
14 In this isolate, the cfr gene was located on a 97 kb conjugative plasmid, designated pHOU-cfr. The cfr gene was flanked by IS256-like sequences.
14 A recent surveillance study also revealed three conjugative cfr-carrying plasmids in Enterococcus spp. from swine and their associated farm environment in China. 16 These included the 55 kb plasmid pW9-2 from E. faecalis ST469 isolate W9-2, and also the 75 kb plasmid pW3 and the 72 kb plasmid p3-38, both from E. thailandicus (Table 1 ). Sequence analysis revealed that these conjugative plasmids had a 4447 bp central region in common, which comprised the cfr gene bracketed by copies of the novel insertion sequence ISEnfa4 located in the same orientation (Figure 1b) . This IS element is most closely related to IS1542 from E. faecium, with an overall nucleotide sequence identity of 91.6% (1213/ 1324 bp) and 93.8% amino acid sequence identity (366/390 amino acids) in the transposase protein. 16 This newly designated IS element and the associated cfr gene showed a high degree of nucleotide sequence identity (.99%) to the IS256-like element and cfr gene found in both the Enterococcus plasmid pHOU-cfr and the Staphylococcus plasmid pSS-01. This observation might suggest that the cfr gene and ISEnfa4 on staphylococcal plasmid pSS-01 have originated from an enterococcal species. Further analysis of the three conjugative enterococcal plasmids of veterinary origin revealed the presence of a v-1-z toxin-antitoxin module, which exhibited .95% nucleotide sequence identity to that of the conjugative plasmid pAMb1 from E. faecalis.
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In addition, a 32 kb non-conjugative plasmid (pEF-01) carrying cfr has been described in E. faecalis isolate EF-01, which was isolated from bovine faeces in the Sichuan province, China. 13 The genetic environment of the cfr gene on this plasmid was distinct from that of other cfr-carrying plasmids or chromosomal segments (Figure 1b) . Three copies of the insertion sequence IS1216 were identified, and the detection of cfr-and IS1216-containing amplicons by inverse PCR suggested that IS1216 might have played a role in the dissemination of cfr in Review enterococci via recombination processes. Moreover, a novel phenicol exporter gene, fexB, was present on this plasmid. 47 
Genetic environment of cfr in Gram-negative bacteria cfr in Proteus vulgaris
Although cloning experiments showed that cfr is functionally active in enterobacterial hosts, such as Escherichia coli, 8 there was no information available regarding the presence of cfr in naturally occurring Gram-negative bacteria. This situation changed with the identification of the Proteus vulgaris isolate PV-01, obtained from a porcine nasal swab in China in 2011, which carried cfr and the florfenicol exporter gene floR. 18 An 7 kb segment that contained the cfr gene was found to be inserted into the chromosomal fimD gene of PV-01. The region flanking the cfr gene showed partial homology to plasmid pKKS825 from MRSA strain ST398. 40 In addition, this inserted segment was flanked by IS26 elements located in the same Review orientation, which are believed to have played a role in the integration process (Figure 1c ). Stability testing via inverse PCR approaches showed that the integration was not entirely stable, and that the cfr-carrying centre region plus one IS26 copy could be looped out via IS26-mediated recombination. 18 cfr in E. coli
Following the discovery of the cfr gene in a naturally occurring P. vulgaris isolate, a survey was conducted to investigate the presence and genetic environment of this multiresistance gene in E. coli isolates from food-producing animals. In total, 1230 E. coli isolates, collected from pigs, chickens and ducks in China between 2008 and 2010, were screened for the presence of cfr. Only a single isolate, E. coli EC-01, obtained from the nasal swab of a pig from a slaughterhouse, harboured the cfr gene. 19 The cfr gene was located on the 110 kb plasmid pEC-01, which contains an IS26-flanked 1545 bp cfr-carrying segment identical to the corresponding region of the staphylococcal plasmid pSCFS1. 19 Similarly to the situation in P. vulgaris, this cfr-carrying segment plus one IS26 copy could also be looped out via IS26-mediated recombination. Moreover, the IS26 transposition created a new hybrid promoter in which the 235 region was part of the left inverted repeat of IS26, while the 210-like sequence was part of the original cfr upstream region. 19 The regions flanking the two IS26 elements on pEC-01 showed a high degree of homology (.96%) to plasmid pCROD2 (GenBank accession no. NC_013718) from Citrobacter rodentium ICC168, 48 and to plasmid pBS512_33 (GenBank accession no. NC_010657) from Shigella boydii CDC 3083-94, suggesting that a 3849 bp element containing the cfr gene, both IS26 elements and the transposase gene tnpA had integrated into a pCROD2-like or pBS512_33-like backbone. 19 Although cfr has so far been identified only in single isolates of P. vulgaris and E. coli, the insertion element IS26 appears to play an important role in the transfer of this multiresistance gene in Gramnegative bacteria. Moreover, IS26 is widespread among Gramnegative bacterial plasmids, and also shares significant homology with the staphylococcal insertion sequences IS431 and IS257, 49 which are present on various staphylococcal plasmids as well as within certain SCCmec cassettes of MRSA strains. Thus the cfr gene may not only be disseminated within Gram-negative bacteria via IS26-mediated recombination events, but may also be re-introduced into the Gram-positive gene pool.
Conclusions and perspectives
It is still uncertain whether the cfr gene originally evolved to protect its hosts against certain antimicrobial agents that inhibit protein biosynthesis, or whether it also has some other functions. Phylogenetic comparisons have shown that Cfr is similar to the RlmN methyltransferase that adds a methyl group at the C-2 position of 23S rRNA nucleotide A2503, the same nucleotide that is methylated by Cfr. 50 Recently, an interesting study verified the functionality of three cfr-like genes (.50% amino acid identity to Cfr) from Bacillales hosts, indicating that cfr-like genes are present in the environment and may be acquired by environmental bacteria. 5 There may be several reasons for the emergence and dissemination of the cfr gene in clinical, veterinary and environmental bacteria. Unlike the reduced fitness observed among linezolid-resistant isolates that carry mutations in their 23S rRNA genes, the transferable cfr gene appears to have a low fitness cost in Gram-positive bacteria. 51 Under the selective pressure of antimicrobial agents to which cfr confers resistance, e.g. oxazolidinones and lincosamides in human medicine as well as phenicols, lincosamides and pleuromutilins in veterinary medicine, this low fitness cost may not have a negative impact on the acquisition and further dissemination of the cfr gene. 4, 7 Moreover, many plasmids that carry the cfr gene-especially those found in staphylococci-harbour additional resistance genes, which may enable the co-selection of the cfr gene and its persistence even in the absence of a direct selective pressure. Among them, aminoglycoside and MLS B resistance genes have been most frequently observed. It is also noteworthy that the simultaneous presence of cfr and erm genes results in resistance to clinically used streptogramin A+ B combinations, such as quinupristin/dalfopristin, as cfr confers resistance to the streptogramin A compound and the erm genes confer resistance to the streptogramin B compound.
The location of cfr on plasmids, including conjugative plasmids, is a key factor for its dissemination across strain, species and genus boundaries. This has been confirmed not only by the identification of the same plasmids in different strains of the same staphylococcal species, 23 but also by the presence of the same plasmid in different staphylococcal species 20, 23 and even in different Gram-positive bacteria. 17, 23 Another aspect is that several different insertion sequences are involved in the mobility of the cfr gene. Such insertion sequences, including IS21-558, ISEnfa4, IS1216 and IS26, are widely disseminated in the different Gram-positive and Gram-negative bacteria and allow translocation of the cfr gene between different plasmids, as well as mediating its integration into chromosomal DNA. Knowledge of the genetics of cfr-mediated resistance-as summarized in this review-is essential for understanding how this gene could have emerged over the past decade in different parts of the world.
Based on the flexibility of bacteria to accept foreign resistance genes and the mobility of the cfr gene, it is likely that this gene will in future also be found in bacteria other than the ones listed in this review. The most efficient way of limiting the spread of this multiresistance gene is to reduce the selective pressure for cfr and other coexisting resistance genes. This can only be achieved by the prudent use of phenicols, lincosamides, and pleuromutilins, and also macrolides and aminoglycosides, in animal production and veterinary medicine. The same applies to the use of oxazolidinones, lincosamides and streptogramins, as well as macrolides and aminoglycosides, in human medicine. In addition, continued surveillance and molecular epidemiological analysis of this multiresistance gene among Gram-positive and Gram-negative bacteria in both human and veterinary medicine are warranted to identify the origins of cfr-positive bacteria and limit their dissemination.
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